US sends experimental Ebola drug to DRC as outbreak trials expand
AI Summary
The U.S. has taken a significant step in the fight against the Ebola outbreak in the Democratic Republic of Congo by providing experimental antibody drugs for clinical trials. This move underscores the escalating urgency and scale of the outbreak, as the trials expand to include more patients. While the efficacy of these experimental treatments remains uncertain, their deployment highlights the global community's commitment to finding a solution to curb the virus's spread.
Original Source
Read the full article at Dailysabah →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.